Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/12/2003WO2003047631A2 Clasp-pna-conjugate for the specific transport of nucleic acids which are thermally active
06/12/2003WO2003047617A2 Vaccine
06/12/2003WO2003047616A1 Migration of hematopoietic stem cells and progenitor cells to th e liver
06/12/2003WO2003047613A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047547A2 Prenyltransferase from plants
06/12/2003WO2003047532A2 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
06/12/2003WO2003047527A2 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
06/12/2003WO2003047525A2 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
06/12/2003WO2003047507A2 Factor viii c2 domain variants
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047421A2 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003WO2003047420A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003WO2003047336A2 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES
06/12/2003WO2003038098A3 5t4 ligand
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003026399A3 Gng4 gene disruptions, compositions and methods related thereto
06/12/2003WO2003025175A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
06/12/2003WO2003020951A3 Identification of a novel group ii intron splicing factor
06/12/2003WO2003020734A3 Labeled nucleoside polyphosphates
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002100894A3 Dna encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (pgc-1), detection methods and test kits therefor
06/12/2003WO2002068627A3 Vector constucts
06/12/2003WO2002061088A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
06/12/2003WO2002055692A3 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease
06/12/2003WO2002046442A3 Phosphatase stress-related proteins and methods of use in plants
06/12/2003WO2002046435A3 Engineered plasmids and their use for in situ production of genes
06/12/2003WO2002020758A3 Novel proteins and nucleic acids encoding same
06/12/2003WO2002016623A8 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2002005205A3 Method and system for modeling biological systems
06/12/2003WO2002000844A3 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
06/12/2003WO2001088188A3 Method for examining ischemic conditions
06/12/2003WO2001088126A8 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
06/12/2003WO2001085096A9 Mast cell regulation
06/12/2003WO2001083701A8 Light-driven energy generation using proteorhodopsin
06/12/2003WO2001073133A9 Compositions and methods for identifying and targeting cancer cells
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003WO2000040737A9 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
06/12/2003US20030110537 Removal germ form seeds; transforming plant tissue
06/12/2003US20030110536 Controlling endosperm; modulation ofgene expression
06/12/2003US20030110535 Transforming gene using enzyme; potatoes; discoloration inhibition
06/12/2003US20030110534 Monocotyledon plant cells and plants which synthesise modified starch
06/12/2003US20030110533 Acetyl-CoA carboxylase subunits
06/12/2003US20030110532 Methods for enhancing segregation of transgenes in plants and compositions thereof
06/12/2003US20030110531 Transformation by particle bombardment; wheat; synergistic mixture of thidiazuion and auxin
06/12/2003US20030110530 Genetic engineered nucleic acids; transformation; resists parasites, nematodes, insects, pests
06/12/2003US20030110529 Genetic engineering gene expression cassette; adjustment protein cell cycles; plants
06/12/2003US20030110528 Novel ecdysone receptors and methods for their use
06/12/2003US20030110523 Determination genotypes
06/12/2003US20030110522 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the PSP94 gene
06/12/2003US20030110520 Isolation and characterization of a N. crassa silencing gene and uses thereof
06/12/2003US20030110519 Cognition activators, sleep disorders, eating disorders, psychological disorders
06/12/2003US20030110169 System and method for providing manageability to security information for secured items
06/12/2003US20030109699 Biopolymers; gene therapy, medical diagnosis
06/12/2003US20030109696 Nucleic acid purification
06/12/2003US20030109693 Chondroitin polymerase and DNA encoding the same
06/12/2003US20030109692 Protein G receptors; autoimmune disease, antidiabetic agents, anticancer agents
06/12/2003US20030109691 Variant integrin polypeptides and uses thereof
06/12/2003US20030109685 Schizophrenic, psychological disorders, Parkinson's disease; genetic engineered polypeptide
06/12/2003US20030109683 Hybrid proteins; controlling gene expression in gene therapy; Parkinson's disease
06/12/2003US20030109678 Methods and means for regulation of gene expression
06/12/2003US20030109676 Human endothelin-bombesin receptor
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109618 Magnetic, silanised polyvinylalcohol-basedcarrier materials
06/12/2003US20030109481 Tumour-cell specific gene expression and its use in cancer therapy
06/12/2003US20030109480 Inhibitors of endothelin-1 synthesis
06/12/2003US20030109478 Nucleic acid formulations for gene delivery and methods of use
06/12/2003US20030109477 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/12/2003US20030109476 Compositions and methods for the prevention and treatment of Huntington's disease
06/12/2003US20030109475 Introducing a gene capable of modulating the genotype and phenotype into two or more tissues following systemic administration. The gene can be introduced into a mammalian host by way of an expression vector either as naked DNA or
06/12/2003US20030109474 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and
06/12/2003US20030109472 Replicating adenovirus vectors
06/12/2003US20030109470 Variants thereof, are described wherein a nucleic acid sequence of the invention exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers such as those listed expression of a nucleic acid
06/12/2003US20030109469 Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
06/12/2003US20030109467 Antisense modulation of human FXR expression
06/12/2003US20030109466 Antisense modulation of KSR expression
06/12/2003US20030109465 TGF- beta blocking agent-treated HSC compositions and methods comprising the same. The TGF- beta blocking agent-treated stem cells are viable for an extended time in culture without replication or differentiation and upon transfer to conditions
06/12/2003US20030109454 Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof
06/12/2003US20030109448 Enhancing cellular uptake and redistributing gene regulating polyamides from the extranuclear areas in eukaryotic cells to the nucleus thereof. The method consists of administering to the eukaryotic cells a molecular trafficking compound
06/12/2003US20030109439 Keratinocyte growth factor (KGF) polypeptides and methods of using the same are described. The KGF polypeptides of the present invention display enhanced bioactivity relative to full-length KGF163 in lower concentrations
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109436 Wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. DNA sequence codes for cells
06/12/2003US20030109434 One or more kidney tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expression such
06/12/2003US20030109430 Immunoassays for human and canine brain natriuretic peptide
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109420 Diagnostic markers of acute coronary syndrome and methods of use thereof
06/12/2003US20030109045 Stabilization of gene expression; plant sindbis virus
06/12/2003US20030109042 Stimulant immunology system; cell differentiation; culture product; three-dimensional support
06/12/2003US20030109038 Chondrocyte precursors derived from human embryonic stem cells
06/12/2003US20030109027 Tumor suppression genes
06/12/2003US20030109026 Genetically modified tumor-targeted bacteria with reduced virulence
06/12/2003US20030109024 Translation of messenger Rna; genetic engineering protein
06/12/2003US20030109022 Asp2
06/12/2003US20030109018 Novel endometriosis-associated gene
06/12/2003US20030109016 Tumor suppresison gene; anticancer agents
06/12/2003US20030109013 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid
06/12/2003US20030109012 Fermentation enterobacter
06/12/2003US20030109011 Methods for the cost-effective saccharification of lignocellulosic biomass
1 ... 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 ... 4023